Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : Nabi (NABI) -- Ignore unavailable to you. Want to Upgrade?

To: Extra Pale who wrote (273)	9/3/2000 2:53:21 PM
From: Oak Tree	Respond to of 354

Mike, I mostly agree. First I believe that we can expect prices over $10 (though I'm not sure how much volume), I also think that a successful StaphVax could cause a good spike, but I don't think that anything will hold with the volatility of techs including biotechs. I think that I will unload most of my shares on a good spike, since I think it reasonable to expect to reload at $7-7 1/2 again. Remember there are a lot of newly offered shares ($10M) purchased in that range very recently. NicVax however is really cool, and could make this a $50 stock. Hence, no danger in going long, and ultimately a danger in missing the ten-for if I get too greedy or try to time it too well. Oak.